https://druggenius.com/news/asia-pacific-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-176/ 2020-08-02T08:01:27+00:00 https://druggenius.com/news/europe-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-173/ 2020-08-02T08:01:23+00:00 https://druggenius.com/news/boosting-investment-in-ri-e100000-donation-by-kenup-foundation-to-maltas-covid-19-rd-fund-95/ 2020-08-02T08:01:09+00:00 https://druggenius.com/news/asia-pacific-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-165/ 2020-08-02T05:16:23+00:00 https://druggenius.com/news/europe-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-162/ 2020-08-02T05:16:19+00:00 https://druggenius.com/news/boosting-investment-in-ri-e100000-donation-by-kenup-foundation-to-maltas-covid-19-rd-fund-84/ 2020-08-02T05:16:06+00:00 https://druggenius.com/news/global-peripheral-arterial-disease-pipeline-monitor-2020-drugs-companies-clinical-trials-rd-updates-/ 2020-08-02T05:01:33+00:00 https://druggenius.com/news/asia-pacific-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-164/ 2020-08-02T05:01:27+00:00 https://druggenius.com/news/global-aerospace-life-sciences-testing-inspection-and-certification-tic-market-to-surpass-59-3-billi/ 2020-08-02T02:01:40+00:00 https://druggenius.com/news/global-butterfly-needle-sets-market-opportunity-analysis-industry-forecast-2020-researchandmarkets-c/ 2020-08-02T02:01:36+00:00 https://druggenius.com/news/asia-pacific-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-152/ 2020-08-02T02:01:27+00:00 https://druggenius.com/news/europe-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-149/ 2020-08-02T02:01:23+00:00 https://druggenius.com/news/boosting-investment-in-ri-e100000-donation-by-kenup-foundation-to-maltas-covid-19-rd-fund-71/ 2020-08-02T02:01:10+00:00 https://druggenius.com/news/asia-pacific-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-108/ 2020-08-01T15:01:26+00:00 https://druggenius.com/news/europe-biodefense-market-2020-trend-forecast-growth-opportunity-researchandmarkets-com-105/ 2020-08-01T15:01:22+00:00 https://druggenius.com/news/boosting-investment-in-ri-e100000-donation-by-kenup-foundation-to-maltas-covid-19-rd-fund-27/ 2020-08-01T15:01:09+00:00 https://druggenius.com/news/international-sos-announces-successful-pilot-test-of-icc-aokpass-with-energy-drilling-providing-trus/ 2020-07-30T07:31:27+00:00 https://druggenius.com/news/bradley-corp-shares-six-ways-the-pandemic-is-transforming-restroom-design/ 2020-07-07T14:16:13+00:00 https://druggenius.com/news/covid-19-impact-recovery-analysis-clinical-trial-supplies-market-2020-2024-evolving-opportunities-wi/ 2020-07-04T22:16:07+00:00 https://druggenius.com/news/global-hydroxychloroquine-market-is-estimated-to-be-us-2-7-billion-by-2029-with-a-cagr-of-5-3-during/ 2020-06-15T19:05:10+00:00 https://druggenius.com/news/polydex-pharmaceuticals-issues-first-quarter-financial-results/ 2020-06-15T18:00:10+00:00 https://druggenius.com/news/phathom-pharmaceuticals-provides-clinical-trial-status-update/ 2020-06-15T17:30:10+00:00 https://druggenius.com/news/pra-enhances-covid-19-monitoring-program-with-integration-of-microsoft-healthcare-bot-service/ 2020-06-12T17:05:10+00:00 https://druggenius.com/news/cytodyn-reached-its-enrollment-target-for-phase-2-covid-19-trial-for-mild-to-moderate-indication-pri/ 2020-06-12T01:05:10+00:00 https://druggenius.com/news/redhill-biopharma-submits-covid-19-clinical-trial-application-for-phase-2-3-study-with-opaganib/ 2020-06-10T16:00:10+00:00 https://druggenius.com/news/drs-pourhassan-and-kelly-of-cytodyn-to-hold-conference-call-to-provide-updates-on-covid-19-phase-2-a/ 2020-06-09T15:00:10+00:00 https://druggenius.com/news/novavax-president-of-rd-dr-gregory-glenn-to-discuss-the-development-of-covid-19-vaccines-on-panel-at/ 2020-06-09T01:05:10+00:00 https://druggenius.com/news/cytokinetics-to-participate-in-upcoming-investor-conferences/ 2020-06-09T01:00:10+00:00 https://druggenius.com/news/new-book-surveys-biotechnology-thought-leaders-on-covid-19/ 2020-06-08T19:30:10+00:00 https://druggenius.com/news/constellation-pharmaceuticals-announces-appointment-of-dr-jeffrey-humphrey-as-chief-medical-officer/ 2020-06-08T17:00:10+00:00 https://druggenius.com/news/onconova-therapeutics-announces-presentation-at-bio-digital-2020/ 2020-06-08T17:00:10+00:00 https://druggenius.com/news/new-study-demonstrates-genesight-psychotropic-better-predicts-blood-drug-levels-when-compared-to-sin/ 2020-06-08T16:05:10+00:00 https://druggenius.com/news/redhill-biopharma-to-provide-update-on-its-covid-19-and-other-development-programs-at-medinvest-virt/ 2020-06-08T16:00:10+00:00 https://druggenius.com/news/proqr-announces-virtual-presentation-of-phase-1-2-sepofarsen-data-through-the-association-for-resear/ 2020-06-08T16:00:00+00:00 https://druggenius.com/news/cytodyn-receives-bla-acknowledgment-letter-from-the-fda/ 2020-06-08T15:00:10+00:00 https://druggenius.com/news/mateon-announces-an-expansion-to-its-pharmaceutical-manufacturing-ai-camera-grid-by-including-contac/ 2020-06-08T14:00:10+00:00 https://druggenius.com/news/cytodyn-to-present-at-wall-street-reporters-livestream-event-on-june-2-2020-at-1230-pm-et-930-am-pt/ 2020-06-01T15:15:10+00:00 https://druggenius.com/news/cytodyn-files-request-with-fda-for-priority-review-of-bla-for-first-approval/ 2020-06-01T15:00:10+00:00 https://druggenius.com/news/bellicum-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2020-05-30T01:06:38+00:00 https://druggenius.com/news/constellation-pharmaceuticals-to-participate-in-investor-conference/ 2020-05-29T18:00:10+00:00 https://druggenius.com/news/corvus-pharmaceuticals-presents-updated-clinical-data-supporting-and-refining-the-adenosine-gene-sig/ 2020-05-29T17:00:10+00:00 https://druggenius.com/news/phathom-pharmaceuticals-to-present-at-upcoming-investor-conferences/ 2020-05-29T01:30:10+00:00 https://druggenius.com/news/unity-biotechnology-to-participate-in-the-goldman-sachs-41st-annual-global-healthcare-conference/ 2020-05-29T01:05:10+00:00 https://druggenius.com/news/geron-corporation-reports-first-quarter-2020-financial-results/ 2020-05-29T01:05:10+00:00 https://druggenius.com/news/illegal-online-pharmacies-exploit-vulnerable-consumers-during-the-covid-19-pandemic/ 2020-05-26T21:30:10+00:00 https://druggenius.com/news/novavax-initiates-phase-1-2-clinical-trial-of-covid-19-vaccine/ 2020-05-26T01:30:10+00:00 https://druggenius.com/news/cytodyn-to-hold-conference-call-to-provide-updates-on-covid-19-phase-2-3-eind-cancer-mtnbc-phase-2-f/ 2020-05-23T05:49:24+00:00 https://druggenius.com/news/ritter-pharmaceuticals-inc-announces-expected-closing-of-merger-transaction-with-qualigen-inc/ 2020-05-22T21:35:10+00:00 https://druggenius.com/news/equillium-to-present-at-jefferies-virtual-healthcare-conference/ 2020-05-22T01:07:10+00:00 https://druggenius.com/news/macrogenics-to-host-conference-call-and-webcast-to-review-preliminary-clinical-results-for-mgd013-an/ 2020-05-22T01:05:10+00:00 https://druggenius.com/news/geron-announces-plans-for-imetelstat-phase-3-clinical-trial-in-myelofibrosis-and-other-updates/ 2020-05-22T01:01:10+00:00 https://druggenius.com/news/u-s-department-of-health-human-services-teams-with-morehouse-school-of-medicine-to-deliver-distance-/ 2020-05-21T21:59:32+00:00 https://druggenius.com/news/apollomics-inc-announces-initiation-of-sparta-phase-2-clinical-trial-for-c-met-inhibitor-apl-101/ 2020-05-21T16:10:10+00:00 https://druggenius.com/news/marius-pharmaceuticals-announces-issuance-of-two-key-patents-protecting-its-proprietary-oral-testost/ 2020-05-21T15:30:10+00:00 https://druggenius.com/news/fda-approves-two-emergency-inds-to-administer-organicell-flow-for-covid-19/ 2020-05-19T16:00:10+00:00 https://druggenius.com/news/cytodyn-and-the-mexican-national-institutes-of-health-participate-in-a-collaborative-study-of-leronl/ 2020-05-19T15:00:10+00:00 https://druggenius.com/news/cytodyn-to-prepare-a-phase-3-protocol-to-submit-to-the-fda-for-a-three-arm-comparative-and-combinati/ 2020-05-18T15:00:10+00:00 https://druggenius.com/news/cytodyn-to-offer-no-cost-exploratory-laboratory-testing-for-childhood-inflammatory-disease-associate/ 2020-05-15T15:00:10+00:00 https://druggenius.com/news/cytodyn-completed-submission-of-all-remaining-parts-of-biologics-license-application-bla-on-may-11-2/ 2020-05-13T15:00:10+00:00 https://druggenius.com/news/gevo-reports-first-quarter-2020-financial-results/ 2020-05-13T01:05:10+00:00 https://druggenius.com/the-mind/ocd-vs-ocpd-whats-the-difference-symptoms-treatments/ 2020-05-12T19:26:11+00:00 https://druggenius.com/news/interesting-films-and-disabled-hollywood-director-stephan-pacheco-unveil-brand-new-movie-about-heroi/ 2020-05-12T18:00:10+00:00 https://druggenius.com/news/aquabounty-technologies-engages-mz-group-to-lead-investor-relations-and-shareholder-communication-pr/ 2020-05-12T17:30:10+00:00 https://druggenius.com/news/phathom-pharmaceuticals-reports-first-quarter-2020-results/ 2020-05-12T17:30:10+00:00 https://druggenius.com/news/seelos-therapeutics-to-participate-in-the-jefferies-virtual-healthcare-conference/ 2020-05-12T17:01:10+00:00 https://druggenius.com/news/arbutus-to-present-at-ubs-virtual-global-healthcare-conference/ 2020-05-12T17:00:10+00:00 https://druggenius.com/news/catalyst-pharmaceuticals-announces-first-quarter-2020-financial-results-and-provides-corporate-updat/ 2020-05-12T01:17:10+00:00 https://druggenius.com/news/novavax-reports-first-quarter-2020-financial-results/ 2020-05-12T01:05:10+00:00 https://druggenius.com/news/novavax-to-receive-up-to-388-million-funding-from-cepi-for-covid-19-vaccine-development-and-manufact/ 2020-05-12T01:02:10+00:00 https://druggenius.com/news/liquidia-reports-first-quarter-2020-financial-results-and-provides-corporate-update/ 2020-05-12T01:01:10+00:00 https://druggenius.com/news/novavax-to-present-covid-19-vaccine-candidate-progress-in-world-vaccine-congress-webinar-series/ 2020-05-11T20:53:08+00:00 https://druggenius.com/news/onconova-therapeutics-announces-virtual-format-for-2020-annual-meeting-of-stockholders/ 2020-05-11T17:00:10+00:00 https://druggenius.com/news/ritter-pharmaceuticals-regains-compliance-with-nasdaqs-stockholders-equity-requirement-for-continued/ 2020-05-11T17:00:10+00:00 https://druggenius.com/news/myriad-receives-fda-approval-of-mychoice-cdx-as-companion-diagnostic-for-lynparza-olaparib-in-patien/ 2020-05-11T16:05:10+00:00 https://druggenius.com/news/arbutus-reports-first-quarter-2020-financial-results-provides-pipeline-update-and-announces-new-rese/ 2020-05-11T15:00:10+00:00 https://druggenius.com/news/cytodyn-to-present-at-wall-street-reporters-next-superstock-livestream-event-on-may-13-2020-at-1230-/ 2020-05-11T15:00:10+00:00 https://druggenius.com/news/cytodyn-clarifies-status-of-biologics-license-application/ 2020-05-09T04:59:12+00:00 https://druggenius.com/news/redhill-biopharma-receives-fda-approval-for-covid-19-clinical-study-with-opaganib-in-the-u-s/ 2020-05-08T16:00:10+00:00 https://druggenius.com/news/novant-health-initiates-phase-2b-3-trial-with-cytodyns-leronlimab-for-severely-and-critically-ill-co/ 2020-05-08T03:19:01+00:00 https://druggenius.com/news/manuscript-describes-how-cytodyns-leronlimab-disrupts-ccl5-rantes-ccr5-pathway-thereby-restoring-imm/ 2020-05-06T10:24:13+00:00 https://druggenius.com/news/organicell-announces-fda-approval-of-ind-application-for-the-treatment-of-sars-due-to-covid-19/ 2020-05-05T17:00:10+00:00 https://druggenius.com/news/fda-approves-54-emergency-inds-for-leronlimab-treatment-of-coronavirus-cytodyn-requests-compassionat/ 2020-05-04T15:00:10+00:00 https://druggenius.com/fitness/ballistic-stretching-benefits-how-and-when-to-do-it/ 2020-04-10T00:06:35+00:00 https://druggenius.com/the-mind/rejection-sensitive-dysphoria-symptoms-causes-diagnosis/ 2020-04-09T23:32:57+00:00 https://druggenius.com/the-mind/stress-management-activities-techniques-to-relieve-stress/ 2020-04-09T23:30:24+00:00 https://druggenius.com/the-mind/cluster-b-personality-disorders-traits-causes-treatment/ 2020-04-09T21:31:43+00:00 https://druggenius.com/neo-adjuvant-t-vec-nivolumab-combination-therapy-for-resectable-early-metastatic-stage-iiib-c-d-iv-m/ 2020-04-07T07:41:11+00:00 https://druggenius.com/news/unity-biotechnology-completes-enrollment-in-phase-1b-study-of-ubx0101/ 2020-04-01T01:05:10+00:00 https://druggenius.com/news/osteoporosis-drugs-market-to-reach-10-47-billion-by-2026-amr/ 2020-03-31T19:38:19+00:00 https://druggenius.com/health-2/esophagus-stretching/ 2020-03-31T18:01:31+00:00 https://druggenius.com/fitness/best-running-shoes-for-plantar-fasciitis/ 2020-03-31T16:57:53+00:00 https://druggenius.com/fitness/average-marathon-times/ 2020-03-31T16:44:08+00:00 https://druggenius.com/news/incysus-therapeutics-to-present-at-the-nyc-spring-oncology-investor-conference/ 2020-03-31T16:00:10+00:00 https://druggenius.com/news/cytodyn-completes-non-dilutive-15-million-convertible-note-financing-with-conversion-rate-at-4-50-pe/ 2020-03-31T15:15:10+00:00 https://druggenius.com/news/myriad-seeks-japanese-regulatory-approval-for-its-bracanalysis-diagnostic-system-in-people-with-adva/ 2020-03-30T16:05:10+00:00 https://druggenius.com/news/three-additional-patients-with-severe-covid-19-treated-with-leronlimab-in-new-york-medical-center-br/ 2020-03-30T15:00:10+00:00 https://druggenius.com/the-mind/is-adhd-a-disability/ 2020-03-27T19:01:24+00:00 https://druggenius.com/news/entera-bio-ltd-announces-financial-and-operating-results-for-the-fourth-quarter-and-year-ended-decem/ 2020-03-26T15:30:10+00:00 https://druggenius.com/health/how-to-get-water-out-of-your-ear-8-tips/ 2020-03-20T22:03:58+00:00 https://druggenius.com/news/global-diabetes-drugs-market-2020-to-showing-impressive-growth-by-2025-industry-trends-share-size-to/ 2020-03-02T19:00:10+00:00